CONMED Corporation reported an 8.6% year-over-year increase in sales, reaching $277.2 million for the second quarter of 2022. However, the company experienced a diluted net loss per share of $5.65, compared to a net earnings per share of $0.41 in the same quarter of the previous year. Adjusted diluted net earnings per share were $0.76, a 7.0% increase year over year. The company has lowered its full-year revenue guidance due to changes in foreign exchange rates.
Sales increased by 8.6% year over year to $277.2 million, or 9.8% in constant currency.
Domestic revenue increased 3.9% year over year.
International revenue increased 14.7% year over year as reported and 17.2% in constant currency.
Adjusted diluted net earnings per share were $0.76, an increase of 7.0% over the second quarter of 2021.
Due to changes in foreign exchange rates, the Company is lowering its revenue guidance for the full year 2022 and now expects revenue between $1.095 billion and $1.140 billion. The Company now expects full-year 2022 adjusted diluted net earnings per share in the range of $3.40 to $3.55, down from the prior range of $3.50 to $3.65 to account for a $0.10 currency headwind.
Visualization of income flow from segment revenue to net income